NPI | New Product Implementation

NPI | New Product Implementation

The product then moves to the new product implementation (NPI) phase.

This phase includes a preliminary production portfolio comprising descriptions of the full production process, engineering conclusions, expected challenges and recommendations for production.
These well-established processes enable a seamless product transfer from design to production, which ultimately leads to significantly increased efficiency and reduced costs.

social position

More news

Quasar’s new top-technology production facility

We are happy to announce the opening of our new manufacturing facility in Dongguan, China. The facility is now in the validation phase and will fully operational for mass production during Q1-2018. The new facility is our newest asset in our effort to deliver higher quality and newer technologies for innovative medical device mass production and process-design services.

Quasar passes FDA inspection with no 483 findings

An FDA audit was conducted from October 31 to November 3 at the Quasar manufacturing facility in Shenzhen. This is the second consecutive audit Quasar has passed, by the FDA, and the result with NO findings in non-conformance (no 483) endorses Quasar’s renewed commitment to being a qualified medical device manufacturer. Consistent with Quasar’s legacy of maintaining high quality standards, quality is focused on throughout the entire production process, starting from development, and maintained through all phases to manufacturing.